Nyati MK - Search Results

1

Chaperone Activity and Dimerization Properties of Hsp90α and Hsp90β in Glucocorticoid Receptor Activation by the Multiprotein Hsp90/Hsp70-Dependent Chaperone Machinery.

Morishima Y, Mehta RK, Yoshimura M, Lau M, Southworth DR, Lawrence TS, Pratt WB, Nyati MK, Osawa Y. Morishima Y, et al. Among authors: nyati mk. Mol Pharmacol. 2018 Sep;94(3):984-991. doi: 10.1124/mol.118.112516. Epub 2018 Jun 25. Mol Pharmacol. 2018. PMID: 29941666 Free PMC article.

2

High and selective expression of yeast cytosine deaminase under a carcinoembryonic antigen promoter-enhancer.

Nyati MK, Sreekumar A, Li S, Zhang M, Rynkiewicz SD, Chinnaiyan AM, Rehemtulla A, Lawrence TS. Nyati MK, et al. Cancer Res. 2002 Apr 15;62(8):2337-42. Cancer Res. 2002. PMID: 11956093

3

Small-molecule tyrosine kinase inhibitors as radiosensitizers.

Lawrence TS, Nyati MK. Lawrence TS, et al. Among authors: nyati mk. Semin Radiat Oncol. 2002 Jul;12(3 Suppl 2):33-6. doi: 10.1053/srao.2002.34867. Semin Radiat Oncol. 2002. PMID: 12174343 Review.

4

Regional delivery and selective expression of a high-activity yeast cytosine deaminase in an intrahepatic colon cancer model.

Zhang M, Li S, Nyati MK, DeRemer S, Parsels J, Rehemtulla A, Ensminger WD, Lawrence TS. Zhang M, et al. Among authors: nyati mk. Cancer Res. 2003 Feb 1;63(3):658-63. Cancer Res. 2003. PMID: 12566311

5

Radiosensitization by pan ErbB inhibitor CI-1033 in vitro and in vivo.

Nyati MK, Maheshwari D, Hanasoge S, Sreekumar A, Rynkiewicz SD, Chinnaiyan AM, Leopold WR, Ethier SP, Lawrence TS. Nyati MK, et al. Clin Cancer Res. 2004 Jan 15;10(2):691-700. doi: 10.1158/1078-0432.ccr-1041-03. Clin Cancer Res. 2004. PMID: 14760092

6

Hitting the target: measuring EGFR response to tyrosine kinase inhibitors.

Nyati MK, Lawrence TS. Nyati MK, et al. Cancer Biol Ther. 2005 Dec;4(12):1387-8. doi: 10.4161/cbt.4.12.2451. Epub 2005 Dec 19. Cancer Biol Ther. 2005. PMID: 16418570 Free article. No abstract available.

7

Synergistic effects of gemcitabine and gefitinib in the treatment of head and neck carcinoma.

Chun PY, Feng FY, Scheurer AM, Davis MA, Lawrence TS, Nyati MK. Chun PY, et al. Among authors: nyati mk. Cancer Res. 2006 Jan 15;66(2):981-8. doi: 10.1158/0008-5472.CAN-05-2665. Cancer Res. 2006. PMID: 16424033

8

Integration of EGFR inhibitors with radiochemotherapy.

Nyati MK, Morgan MA, Feng FY, Lawrence TS. Nyati MK, et al. Nat Rev Cancer. 2006 Nov;6(11):876-85. doi: 10.1038/nrc1953. Epub 2006 Oct 12. Nat Rev Cancer. 2006. PMID: 17036041 Review.

9

Ataxia telangiectasia mutated down-regulates phospho-extracellular signal-regulated kinase 1/2 via activation of MKP-1 in response to radiation.

Nyati MK, Feng FY, Maheshwari D, Varambally S, Zielske SP, Ahsan A, Chun PY, Arora VA, Davis MA, Jung M, Ljungman M, Canman CE, Chinnaiyan AM, Lawrence TS. Nyati MK, et al. Cancer Res. 2006 Dec 15;66(24):11554-9. doi: 10.1158/0008-5472.CAN-06-1935. Cancer Res. 2006. PMID: 17178844

10

Effect of epidermal growth factor receptor inhibitor class in the treatment of head and neck cancer with concurrent radiochemotherapy in vivo.

Feng FY, Lopez CA, Normolle DP, Varambally S, Li X, Chun PY, Davis MA, Lawrence TS, Nyati MK. Feng FY, et al. Among authors: nyati mk. Clin Cancer Res. 2007 Apr 15;13(8):2512-8. doi: 10.1158/1078-0432.CCR-06-2582. Clin Cancer Res. 2007. PMID: 17438112

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

58 results

Search Page

Filters